<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="PACA-CA_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001003162">
		<TITLE>ICGC PCAWG Dataset: PACA-CA_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: PACA-CA.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001225804"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225710"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225670"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225803"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225835"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256160"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256161"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256162"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225781"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225694"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256163"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225819"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256164"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256165"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256166"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256167"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225693"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256168"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225739"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256169"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256170"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225751"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225824"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225714"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225838"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225684"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225833"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225699"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256171"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225681"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225667"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225741"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225776"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256172"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225713"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256173"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225711"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256174"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256175"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225701"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225723"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256176"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256177"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256178"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225692"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225799"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225773"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256179"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256180"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256181"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225831"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256182"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225822"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256183"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256184"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225682"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225792"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256185"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225678"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256186"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225702"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256187"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225665"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225728"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225685"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225761"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256188"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225793"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225698"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223789"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256189"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256190"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256191"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223791"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225736"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256192"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256193"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223793"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256194"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223795"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256195"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256196"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223796"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256197"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256198"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225768"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256199"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256200"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256201"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223801"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223802"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256202"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223804"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256203"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256204"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256205"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223806"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256206"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256207"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223809"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223810"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225770"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223811"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225811"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223812"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256208"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223814"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225720"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256209"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225704"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223815"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256210"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256211"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256212"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225700"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256213"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225795"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223817"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256214"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256215"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223819"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223820"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256216"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223821"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225709"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223822"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223823"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256217"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256218"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256219"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256220"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225669"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225823"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225827"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223827"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256221"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223828"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223829"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256222"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256223"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223830"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223831"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256224"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225759"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256225"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225689"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256226"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223834"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256227"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256228"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256229"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223836"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223837"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256230"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223838"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223839"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256231"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256232"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256233"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223841"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223842"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256234"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223844"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256235"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256236"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225742"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256237"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223847"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223848"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223849"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256238"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225674"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256239"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256240"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225752"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256241"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223851"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225762"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223852"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256242"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223854"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223855"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223856"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223857"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256243"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223859"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256244"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223861"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225826"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223862"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223863"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256245"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225802"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223864"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256246"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256247"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256248"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256249"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223867"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256250"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256251"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256252"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256253"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223869"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256254"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256255"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223871"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223872"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223873"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223874"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256256"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256257"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256258"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256259"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256260"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256261"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225812"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256262"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225787"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223877"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223878"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225671"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256263"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256264"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225730"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256265"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256266"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256267"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256268"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256269"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225707"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225705"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225690"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223881"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225818"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223882"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256270"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223884"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256271"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223885"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225753"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256272"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256273"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223887"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223888"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256274"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225676"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256275"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256276"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223890"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223891"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225715"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256277"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256278"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256279"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223893"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256280"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223895"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256281"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223896"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256282"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256283"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223898"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256284"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256285"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256286"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225786"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225817"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223899"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256287"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256288"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256289"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256290"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256291"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256292"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225785"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223902"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225837"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256293"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223903"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256294"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225727"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256295"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256296"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225747"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256297"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256298"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256299"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223907"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223908"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256300"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256301"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256302"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223909"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001256303"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223910"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223911"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225729"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>